/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Daniele Rodolico is a resident physician at the University of Pisa, Italy. He received his MD cum laude from the Catholic University of Milan (UCSC). He was affiliated to research at the Division of Cardiology of the Department of Medicine, Karolinska Institutet, Stockholm. He was also a Visiting Student Trainee at the University of Texas Health Science Center at Houston and a Student Intern at the Cardiovascular Research Center of the Massachusetts General Hospital in Boston under a fellowship from the Giovanni Armenise Foundation at the Harvard Medical School. In 2021, he was a finalist of the Young investigator Award for Clinical Research of the HFA. In 2024, he was selected as Emerging Leader of the World Heart Federation. He is interested in heart failure, hypertension and cardiometabolic diseases.
Mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: an updated systematic review and meta-analysis of randomized clinical trials
Event: Heart Failure 2025
Topic: Pharmacotherapy
Session: Amyloid and acute heart failure therapy advances
